Barclays Upgrades Momenta Pharmaceuticals (MNTA) to Overweight

October 11, 2016 6:50 AM EDT
Get Alerts MNTA Hot Sheet
Price: $14.50 --0%

Rating Summary:
    10 Buy, 3 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 16 | Down: 21 | New: 10
Trade MNTA Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Barclays upgraded Momenta Pharmaceuticals (NASDAQ: MNTA) from Equalweight to Overweight with a price target of $19.00 (from $13.00).

For an analyst ratings summary and ratings history on Momenta Pharmaceuticals click here. For more ratings news on Momenta Pharmaceuticals click here.

Shares of Momenta Pharmaceuticals closed at $11.77 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Hot Upgrades, Upgrades

Related Entities

Barclays

Add Your Comment